Literature DB >> 8966212

Migrant studies in multiple sclerosis.

C R Gale1, C N Martyn.   

Abstract

To re-evaluate how migrant studies contribute to our understanding of the epidemiology and aetiology of multiple sclerosis, we undertook a systematic review of all relevant studies published in English language journals, comparing rates of multiple sclerosis in migrant populations with those in the host country and in the country of origin. Interpretation of migrant studies is difficult. Migrants are seldom representative of the country of origin, tending to be younger, healthier and of higher socioeconomic status. Data quality may be poor, and lack of age-standardisation can mislead when rates are compared. Nevertheless, two consistent patterns can be discerned in these studies of the effect of migration on risk of multiple sclerosis. Migrants who move from an area where the disease is common to an area where it is rarer show a decrease in rate of disease. By contrast, people who migrate in the opposite direction tend to retain the low risk of their country of origin. Results from the few studies which have examined the effect of age at migration on risk of multiple sclerosis suggest that an individual's risk of the disease is largely established during the first two decades of life. Risk of multiple sclerosis can change rapidly between generations: although migrants from low risk countries to high risk countries retain their low risk, their children have a risk of multiple sclerosis that approaches that of the host country. Migrant studies add little to our understanding of the genetics of multiple sclerosis but they emphasise the importance of environmental factors. We discuss several possible interpretations of the patterns seen in migrant studies, including the hypothesis that multiple sclerosis is a sequel to delayed exposure to a common infectious agent. One candidate for such an infectious agent is Epstein-Barr virus.

Entities:  

Mesh:

Year:  1995        PMID: 8966212

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  47 in total

Review 1.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.

Authors:  A Ascherio; K L Munger
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 2.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 3.  Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health.

Authors:  Graham A Rook
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-23       Impact factor: 11.205

Review 4.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

Review 5.  [Prognostic and predictively relevant factors for multiple sclerosis].

Authors:  B Tackenberg; T Schneider-Hohendorf; A Müller; J Schodrowski; H Wiendl
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

Review 6.  Vitamin D: effects on childhood health and disease.

Authors:  Steven A Abrams; Jorge A Coss-Bu; Dov Tiosano
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

Review 7.  [Multiple sclerosis and Epstein-Barr virus : new developments and perspectives].

Authors:  K Ruprecht
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

8.  Body size and risk of MS in two cohorts of US women.

Authors:  Kassandra L Munger; Tanuja Chitnis; Alberto Ascherio
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

9.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 10.  Clinical implications of a possible role of vitamin D in multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2009-04-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.